Integrated Wealth Concepts’s ImmunityBio IBRX Stock Holding History

Integrated Wealth Concepts’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$105K	Buy	11,972 +572	+5%	+$4.33K	﹤0.01%	2315
2026 Q1	$87.4K	Buy	+11,400	New	+$78K	﹤0.01%	2190
2024 Q4	–	Sell	-17,158	Closed	-$63.8K	–	1751
2024 Q3	$63.8K	Hold	17,158	–	–	﹤0.01%	1634
2024 Q2	$108K	Buy	+17,158	New	+$113K	﹤0.01%	1574
2024 Q1	–	Sell	-13,508	Closed	-$67.8K	–	1679
2023 Q4	$67.8K	Hold	13,508	–	–	﹤0.01%	1547
2023 Q3	$22.8K	Sell	13,508 -4,950	-27%	-$9.94K	﹤0.01%	1537
2023 Q2	$51.3K	Buy	18,458 +50	+0.3%	+$141	﹤0.01%	1518
2023 Q1	$34K	Buy	+18,408	New	+$57.2K	﹤0.01%	1316

Other funds holding IBRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Integrated Wealth Concepts's IBRX Position: Q2 2026 in Review

Integrated Wealth Concepts increased its ImmunityBio (IBRX) stake by 5% in Q2 2026, buying an estimated $4.33K and bringing the position to 11,972 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #2315.

Integrated Wealth Concepts first reported a position in IBRX in Q1 2023 and has held it in 8 quarters since. The position peaked at $108K in Q2 2024. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

Integrated Wealth Concepts held 11,972 shares of ImmunityBio worth $105K as of Q2 2026.
Integrated Wealth Concepts bought 572 ImmunityBio shares in Q2 2026, an estimated $4.33K.
ImmunityBio made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #2315 holding.
Integrated Wealth Concepts first reported a position in ImmunityBio in Q1 2023 and has held it in 8 quarters since.
Integrated Wealth Concepts's ImmunityBio position peaked at $108K in Q2 2024.
405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.